Sign In

Rachel Leibman

Scientific Director specializing in Oncology Clinical Development

Rachel Leibman is a Scientific Director in Oncology Clinical Development at AbbVie, a global pharmaceutical company.1 She is based in San Francisco, California, and specializes in early-phase immuno-oncology clinical development.2

Professional Background

Rachel has a strong background in clinical protocol writing and oncology research. Prior to her current role, she worked at Stemcentrx, an oncology biotech startup that was later acquired by AbbVie.3 Her career progression at AbbVie includes:

  • Starting as an Associate Scientific Director in early-phase immuno-oncology clinical development
  • Advancing to her current position as Scientific Director (Oncology Clinical Development), which she began in August 20234

Education and Expertise

Rachel Leibman holds a degree from the University of Pennsylvania.1 Her expertise includes:

  • Oncology clinical development
  • Immuno-oncology research
  • Clinical protocol writing
  • Early-phase clinical trials

Research Contributions

Rachel has made contributions to the field of oncology research. She has authored or co-authored at least 4 research works, which have received 8 citations.5 One of her notable research contributions includes a first-in-human study of ABBV-514 as monotherapy and in combination with budigalimab.5

Rachel Leibman's LinkedIn profile can be found under the username rachel-leibman-1156a88a, where more details about her professional experience and accomplishments may be available.1

Highlights

Aug 13 · linkedin

I’m happy to share that I’m starting a new position as Scientific Director (Oncology Clinical Development) at AbbVie!

Nov 20 · linkedin

With all the exciting COVID19 vaccine news emerging, it's important to give a shout-out to UPenn Prof. Drew Weissman, whose research on RNA biology laid the groundwork for these vaccines 15 years ago! His IP is being licensed by both Moderna and Pfizer!

Related Questions

What are Rachel Leibman's key achievements at AbbVie?
What was Rachel Leibman's role at Stemcentrx before joining AbbVie?
What specific projects has Rachel Leibman led in oncology clinical development?
How did Rachel Leibman's education at the University of Pennsylvania influence her career?
What are some notable clinical trials Rachel Leibman has been involved in?
Rachel Leibman
Rachel Leibman, photo 1
Rachel Leibman, photo 2
Add to my network

Experience

Scientific Director (Oncology Clinical Development) at AbbVie
Director of Clinical Science at AbbVie (May 2021 - August 2023), Associate Scientific Director at AbbVie (February 2020 - May 2021), Clinical Scientist at AbbVie (June 2017 - February 2020), Doctoral at University of Pennsylvania (September 2011 - May 2017)

Education

PhD in Microbiology from University of Pennsylvania (2011 - 2017), Public Health Certificate from University of Pennsylvania (2011 - 2017), BS in Microbiology from University of Minnesota-Twin Cities

Location

San Francisco, California, United States